News
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...
I ditched carbs, ditched fats, tried any variety of odd combinations from the cabbage diet, or having one sad little packet ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results